D.C. Circuit Ok’s SEC Decision to Deny Whistleblower Awards
Swiss pharmaceutical company Novartis paid $25 million in 2016 to resolve a SEC FCPA enforcement action focused on the conduct of its indirect Chinese subsidiaries.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year